Welcome to Storyflo Daily Biotech. I'm Bea. Today's briefing is all about breaking through the boundaries of biotech innovation.

It's a huge World MS Day tomorrow, and Immunic Therapeutics is making waves with their latest hope for progressive multiple sclerosis. According to Labiotech EU, Immunic's CEO, Dr. Daniel Vitt, has been busy making strides in the field of MS treatment. As one of the most debilitating autoimmune diseases, MS has long been a thorn in the side of patients and researchers alike. Immunic's breakthroughs offer a new light at the end of the tunnel, and it's crucial to keep a close eye on their advancements as they could be a game-changer for the lives of millions. But MS isn't the only condition that's getting a shot in the arm from biotech innovators today. Labiotech EU also highlights the incredible potential of xenotransplantation, 3D bioprinting, and stem cells to ease the global organ shortage crisis. This is more than just science fiction – it's a real chance at a future where transplants can be made more accessible and less scarce. While this technology is still in its early stages, the potential is undeniable. According to experts, this field has the potential to bring a new era of hope and possibilities for those struggling to find matching donors. Meanwhile, big pharma giant Bayer has been making headlines with its latest financial struggles. Labiotech EU notes that with blockbuster sales plummeting, lawsuits on the rise, and patent cliffs looming, Bayer's got a tough road ahead in the coming year. However, the company is not giving up. With several key FDA approvals on the horizon, Bayer is betting big that 2026 will be the year they finally make a comeback. It's a high-stakes gamble, but the potential rewards are too big to ignore. Today's headlines are a stark reminder that the world of biotech is constantly evolving, with new innovations on the horizon and big pharma players fighting for their place in the spotlight. One thing is for sure: the next few years are going to be wild, and Storyflo Daily Biotech is here to keep you ahead of the curve.